Results 181 to 190 of about 948,070 (312)
Turning precision medicine into reality with statistics and data-driven decision making across pharmaceutical development. [PDF]
Desachy G +4 more
europepmc +1 more source
AI-driven pilot platforms and computational pharmaceutics: accelerating innovation in small molecule drug development under industry 4.0 and 5.0 paradigms. [PDF]
Luo K +12 more
europepmc +1 more source
Illegal Drug Usage and Industry [PDF]
openaire +2 more sources
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin +14 more
wiley +1 more source
Using Mandatory Sales Reports to Monitor Same-Day Alcohol Delivery Trends in New South Wales. [PDF]
Taylor N +5 more
europepmc +1 more source
Clinical, histological, and serological predictors of renal function loss in lupus nephritis.
Objective Kidney survival is the ultimate goal in lupus nephritis (LN) management, but long‐term predictors remain inadequately studied, requiring long‐term follow‐up. This study aimed to identify baseline and early longitudinal predictors of kidney survival in the Accelerating Medicines Partnership LN longitudinal cohort.
Shangzhu Zhang +21 more
wiley +1 more source
Essence of toxicology research to Saudi Arabia Vision 2030 and beyond: Current state and future perspectives. [PDF]
Alsaleh NB.
europepmc +1 more source

